Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesCost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism
Pharmacogenetics and genomics, 09/14/09
Vegter S et al. – ACEi therapy is a cost–saving treatment compared with placebo in nondiabetic nephropathy, irrespective of ACE genotype. However, ACEi therapy saved more costs and more health gains were achieved in the ACE DD genotype than in the ACE II/ID genotype. An alternative treatment featuring a modest increase in effectiveness compared with ACEi therapy for patients with the ACE II/ID genotype can be incorporated in a cost–effective or even cost–saving screen–and–treat strategy.
Related Articles
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease
Annals of Internal Medicine, 10/20/09
Relevance Score: 69%
Recent changes in the landscape of combination RAS blockade
Expert Review of Cardiovascular Therapy, 11/18/09
Relevance Score: 67%
Compliance With the Treatment of Hypertension: The Potential of Combination Therapy
The Journal of Clinical Hypertension, 11/11/09
Relevance Score: 66%
Mucosal (oral and vulval) lichen planus in women: are angiotensin-converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition
Clinical and Experimental Dermatology, 10/30/09
Relevance Score: 65%
FDA approves Micardis as the first treatment in its class to reduce the risk of heart attack, stroke, or death from cardiovascular causes in patients at high cardiovascular risk who are unable to take ACE inhibitors
Boehringer Ingelheim, 10/20/09
Relevance Score: 65%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
The pleiotropy of dioxin toxicity — Xenobiotic misappropriation of the aryl hydrocarbon receptor's alternative physiological roles
Pharmacology & Therapeutics, 12/17/09
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Pharmacology & Therapeutics, 12/16/09
The asymmetric/symmetric activation of GPCR dimers as a possible mechanistic rationale for multiple signalling pathways
Trends in Pharmacological Sciences, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor